Gene · 2288
Papers1,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploratory Transcriptomic, Genomic, Pharmacogenomic, and Cellular Evaluation of FKBP4 in Lung Adenocarcinoma. | Biology (Basel) | 2026 | 42792605 | PubTator, text mining | PubMed |
| Abnormally Low Hemoglobin A1c Due to a Heterozygous Alpha-Globin Variant (Hb I; HBA2 c.49A>G, p.Lys17Glu) in a Geriatric Patient. | Cureus | 2026 | 42757138 | PubTator, text mining | PubMed |
| SAV1 in Cooperation With FKBP52 Participates in Implantation. | Adv Sci (Weinh) | 2026 | 42750339 | PubTator, text mining | PubMed |
| Identification of Mitotic Catastrophe-related Prognostic Genes in Lung Adenocarcinoma via Transcriptome Analysis. | J Vis Exp | 2026 | 42631570 | PubTator, text mining | PubMed |
| Metabolism Pathway Blood Proteomic Differences in Lewy Body Dementia Compared to Alzheimer's Disease. | Int J Mol Sci | 2026 | 42589529 | PubTator, text mining | PubMed |
| FKBP52 dictates the dual role of p53 in hepatocellular carcinoma: Mutation-specific prognostic stratification and therapeutic implications. | J Biol Chem | 2026 | 42556724 | PubTator, text mining | PubMed |
| NOP2-regulated m5C methylation of FKBP4 in promoting lung adenocarcinoma progression. | Exp Cell Res | 2026 | 42526734 | PubTator, text mining | PubMed |
| Identification of Candidate Biomarkers Associated with Mitochondrial Dysfunction and SUMOylation in Heart Failure Based on Bioinformatics Approaches. | J Vis Exp | 2026 | 42441434 | PubTator, text mining | PubMed |
| Integrated multi-omics analysis identifies key microglial subpopulations and therapeutic targets in Parkinson's disease. | Parkinsonism Relat Disord | 2026 | 42430983 | PubTator, text mining | PubMed |
| Machine learning-driven development of a novel unfolded protein response-related gene signature for predicting lung adenocarcinoma patient prognosis. | BMC Cancer | 2026 | 42401850 | PubTator, text mining | PubMed |
| Improved prognostic survival models for pediatric medulloblastoma using high dimensional gene expression data. | BMC Med Genomics | 2026 | 42387537 | PubTator, text mining | PubMed |
| Genomic relationship between polyendocrine metabolic ovarian syndrome and bipolar disorder. | Eur Neuropsychopharmacol | 2026 | 42349268 | PubTator, text mining | PubMed |
| Beyond Inhibition: Rebalancing the Hsp90 Chaperone Network as a Therapeutic Strategy for Alzheimer's Disease. | Drug Des Devel Ther | 2026 | 42221352 | PubTator, text mining | PubMed |
| Association of FKBP4 gene polymorphisms with glucocorticoid efficacy in pediatric systemic lupus erythematosus. | Pediatr Rheumatol Online J | 2026 | 42216044 | PubTator, text mining | PubMed |
| Dual proximity-based interactome mapping of FKBP51 and FKBP52 uncovers shared metabolic networks. | Biochem Biophys Res Commun | 2026 | 42190603 | PubTator, text mining | PubMed |
| FKBP4-mediated reprogramming of H3K4bhb at energy metabolism ameliorates ischemic acute kidney injury. | Int J Biol Macromol | 2026 | 42150658 | PubTator, text mining | PubMed |
| FKBP52 in cancer biology and therapy: molecular mechanisms, signalling networks, and drug targeting of the FKBP protein family. | Biochem Pharmacol | 2026 | 42114681 | PubTator, text mining | PubMed |
| Progesterone resistance in atypical endometrial hyperplasia: Expression and mechanisms of hormone-responsive molecules. | Medicine (Baltimore) | 2026 | 42065161 | PubTator, text mining | PubMed |
| USP7-dependent stabilization of FKBP4 contributes to acquired osimertinib resistance through glycolytic remodeling in NSCLC. | Sci Rep | 2026 | 42031983 | PubTator, text mining | PubMed |
| Evaluation of the impact of glycolysis-related gene signatures on prognosis and therapeutic targeting in lung adenocarcinoma. | Cytotechnology | 2026 | 41987806 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2288/papers